Menu
Back to User profile » Dr Hao-Chien Wang
Papers published by Dr Hao-Chien Wang:
Current Progress of COPD Early Detection: Key Points and Novel Strategies
Lin CH, Cheng SL, Chen CZ, Chen CH, Lin SH, Wang HC
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1511-1524
Published Date: 19 July 2023
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Chen CZ, Sheu CC, Cheng SL, Wang HC, Lin MC, Hsu WH, Lee KY, Perng DW, Lin HI, Lin MS, Lin SH, Tsai JR, Wang CC, Wang CY, Yang TM, Liu CL, Wang TY, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3405-3415
Published Date: 18 December 2021
Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Cheng SL, Li YR, Huang N, Yu CJ, Wang HC, Lin MC, Chiu KC, Hsu WH, Chen CZ, Sheu CC, Perng DW, Lin SH, Yang TM, Lin CB, Kor CT, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2869-2881
Published Date: 18 October 2021
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH
Drug Design, Development and Therapy 2021, 15:515-516
Published Date: 12 February 2021
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH
Drug Design, Development and Therapy 2020, 14:5441-5450
Published Date: 8 December 2020
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:867-874
Published Date: 8 March 2018
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996
Published Date: 11 October 2017
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2477-2485
Published Date: 21 August 2017
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2775-2783
Published Date: 8 November 2016
Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey
Hang LW, Hsu JY, Chang CJ, Wang HC, Cheng SL, Lin CH, Chan MC, Wang CC, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:665-673
Published Date: 30 March 2016
COPD in Taiwan: a National Epidemiology Survey
Cheng SL, Chan MC, Wang CC, Lin CH, Wang HC, Hsu JY, Hang LW, Chang CJ, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2459-2467
Published Date: 11 November 2015
Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
Cheng SL, Su KC, Wang HC, Perng DW, Yang PC
Drug Design, Development and Therapy 2014, 8:601-607
Published Date: 28 May 2014
Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study
Cheng SL, Wang HC, Kuo SH
Drug Design, Development and Therapy 2013, 7:477-484
Published Date: 17 June 2013